GENEVA, March 8 -- WUHAN HUMANWELL INNOVATIVE DRUG RESEARCH AND DEVELOPMENT CENTER LIMITED COMPANY (Room 705-2, Building C7, No.666 Gaoxin Road, Wuhan East Lake High-tech Development ZoneWuhan, Hubei 430075), 武汉人福创新药物研发中心有限公司 (中国湖北省武汉市东湖新技术开发区高新大道666号C7栋705-2室) filed a patent application (PCT/CN2024/114192) for "THIENYLSULFONYL CARBAMATES AS AT2R AGONISTS" on Aug 23, 2024. With publication no. WO/2025/044926, the details related to the patent application was published on M...